Evidence map›Paper›PMID 33233960›Full record

ArticleInternational journal of immunopathology and pharmacology

Aberrant miR-219-5p is correlated with TLR4 and serves as a novel biomarker in patients with multiple organ dysfunction syndrome caused by acute paraquat poisoning.

Yunxiang Dai, Xia Liu, Yuming Gao

Open access · goldAbstract read
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Cytokine changes in fatal cases of paraquat poisoning.American journal of translational research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yunxiang DaiEmergency Department, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong, China.
Xia LiuRadiology Department, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong, China.
Yuming GaoEmergency Department, Qingdao Jiaozhou Central Hospital, Qingdao, Shandong, China.ORCID https://orcid.org/0000-0001-7133-2238
Shuozhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the clinical significance of serum microRNA-219-5p (miR-219-5p) in patients with multiple organ dysfunction syndrome (MODS) caused by acute paraquat (PQ) poisoning, and its correlation with Toll-like Receptor 4 (TLR4). Luciferase reporter assay was used to investigate in vitro the correlation of miR-219-5p with TLR4. Serum miR-219-5p levels were evaluated by quantitative real-time polymerase chain reaction. Serum levels of TLR4, IL-1β, and TNF-α were measured by Enzyme-linked immune sorbent assay (ELISA). ROC analysis was performed to assess the diagnostic significance, Kaplan-Meier survival curves and Cox regression analysis were used to evaluate the prognostic value of miR-219-5p in MODS patients. TLR4 was a target gene of miR-219-5p and was increased in MODS patients. Serum miR-219-5p level was decreased and negatively correlated with TLR4 level in MODS patients (

Indexed as

AdultBiomarkersCytokinesEnzyme-Linked Immunosorbent AssayFemaleHEK293 CellsHerbicidesHumansInflammation MediatorsMaleMicroRNAsMultiple Organ FailureParaquatPredictive Value of TestsPrognosisReal-Time Polymerase Chain ReactionBiomarkersCytokinesHerbicidesInflammation MediatorsMicroRNAsMIRN219 microRNA, humanParaquatTLR4 protein, humanToll-Like Receptor 4diagnosismicroRNA-219-5pmultiple organ dysfunction syndromeparaquat poisoningprognosisTLR4

Identifiers

PMID33233960
PMCPMC7691899
OpenAlexW3106830589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.